NeoGenomics: Warren Stone

新基因组学：沃伦·斯通

NeoGenomics has promoted Chief Commercial Officer Warren Stone to president and chief operating officer (COO), effective April 1. Stone has over 25 years of general management and commercial experience. In his expanded role, he will be responsible for driving the company's lab operations, data solutions division, and enterprise operations functions.

NeoGenomics 已将首席商务官沃伦·斯通 (Warren Stone) 提升为总裁兼首席运营官 (COO)，自 4 月 1 日起生效。斯通拥有超过 25 年的综合管理和商业经验。在他的新职责中，他将负责推动公司的实验室运营、数据解决方案部门及企业运营职能。

Before joining NeoGenomics in 2022, Stone was president of the Americas at Ortho Clinical Diagnostics and senior VP at MilliporeSigma. He earned his MBA from Suffolk University and has a B.A.Sc. in analytical chemistry from Technikon Witwatersrand South Africa. Current NeoGenomics COO Melody Harris will leave the firm at the end of May..

在2022年加入NeoGenomics之前，斯通曾担任奥森临床诊断公司美洲区总裁以及密理博西格玛公司的高级副总裁。他拥有萨福克大学的工商管理硕士学位，并获得南非威特沃特斯兰德技术学院的分析化学学士学位。现任NeoGenomics首席运营官的梅洛迪·哈里斯将于五月底离职。

ACMG: Christa Martin, Josh Deignan, Lauren Massingham, David Miller, Douglas Stewart, William Wilcox

ACMG：克里斯塔·马丁、乔什·德伊格南、劳伦·马辛厄姆、大卫·米勒、道格拉斯·斯图尔特、威廉·威尔科克斯

The American College of Medical Genetics and Genomics appointed six new directors, including a new president-elect, to its board at the 2025 ACMG Annual Clinical Genetics Meeting in Los Angeles this week.

美国医学遗传学与基因组学学院在本周于洛杉矶举行的2025年ACMG年度临床遗传学会议上任命了六名新董事，其中包括一名新当选的候任主席。

The newly elected directors, who will serve six-year terms from March 2025 to March 2031 are:

新当选的董事将从2025年3月至2031年3月任期六年，他们是：

President-elect Christa Martin, currently CSO at Geisinger and vice dean for research at Geisinger's School of Medicine. Martin earned her Ph.D. in human genetics from the University of Pittsburgh and completed her postdoc at the University of Chicago, where she became board-certified in clinical cytogenetics.

当选总统克里斯塔·马丁，现任盖辛格首席战略官（CSO）兼盖辛格医学院研究副院长。马丁在匹兹堡大学获得人类遗传学博士学位，并在芝加哥大学完成博士后研究，期间她获得了临床细胞遗传学的委员会认证。

At Geisinger, she has pioneered initiatives like the MyCode Community Health Initiative and was the founding director of Geisinger's Autism & Developmental Medicine Institute..

在Geisinger，她开创了诸如MyCode社区健康倡议等项目，并且是Geisinger自闭症与发育医学研究所的创始主任。

Josh Deignan, a board-certified clinical geneticist and clinical professor of pathology and laboratory medicine at the David Geffen School of Medicine at the University of California, Los Angeles.

约书亚·德伊根，加州大学洛杉矶分校大卫·格芬医学院病理学和实验室医学临床遗传学家、临床教授。

Lauren Massingham, a board-certified medical geneticist and current director of the cancer genetic program at Hasbro Children's Hospital and Rhode Island Hospital.

劳伦·马辛厄姆，是一名获得认证的医学遗传学家，同时担任哈斯布鲁儿童医院和罗德岛医院癌症遗传项目的现任主任。

David Miller, a board-certified clinical geneticist who directs the Neurofibromatosis Research Initiative at Boston Children's Hospital and is also an associate molecular pathologist at Brigham and Women's Hospital.

戴维·米勒（David Miller）是波士顿儿童医院神经纤维瘤病研究计划的负责人，也是布里格姆妇女医院的副分子病理学家。

Douglas Stewart, a board-certified medical geneticist and internist who serves as a senior investigator at the National Cancer Institute and adjunct investigator at NHGRI.

道格拉斯·斯图尔特，是一名拥有医学遗传学和内科双重认证的专家，同时担任美国国家癌症研究所高级研究员及NHGRI兼职研究员。

William Wilcox, a board-certified clinical geneticist and biochemical geneticist who serves as medical director of the Emory Genetic Clinical Trials Center and is the founder of the Medical Biochemical Genetics Training Program at Emory.

威廉·威尔科克斯是埃默里遗传临床试验中心的医学主任，也是埃默里大学医学生物化学遗传学培训项目的创始人，他是一名获得认证的临床遗传学家和生化遗传学家。

Seek Labs: Kim Wirthlin

Seek实验室：Kim Wirthlin

Point-of-care testing and therapeutics firm Seek Labs has appointed Kim Wirthlin as its chief strategy officer, effective March 17. She has more than 25 years of experience in university leadership, government relations, academic healthcare, and early-stage company development. Prior to joining Salt Lake City-based Seek Labs, Wirthlin was president and chief operating officer of the Huntsman Cancer Foundation.

即时检测和治疗公司Seek Labs任命Kim Wirthlin为其首席战略官，自3月17日起生效。她拥有超过25年的大学领导、政府关系、学术医疗保健及早期公司发展经验。在加入位于盐湖城的Seek Labs之前，Wirthlin曾担任亨茨曼癌症基金会的总裁兼首席运营官。

Before that she spent 18 years as a member of the executive management team at University of Utah Health..

在此之前，她花了18年时间担任犹他大学健康学院的行政管理团队成员。

For additional recent items on executive appointments, promotions, and departures in the omics and molecular diagnostics space, please see the

有关组学和分子诊断领域高管任命、晋升和离职的更多近期信息，请参阅

People in the News page

新闻人物页面

on our website.

在我们的网站上。